Aim Several prognostic histological features have been established in female breast cancer
(BC), but it is unknown whether these can be extrapolated to male BC patients. The aim of …

Context.—The rate of male breast cancer is a small fraction of that observed in females, thus
severely limiting our understanding of the pathogenesis of this condition. It remains unclear …

Male breast cancer (MBC) is rare, accounting for less than 1% of all breast cancer but the
incidence has increased worldwide. Risk factors include increased longevity, obesity …

Gene amplification is an important mechanism for oncogene activation, a crucial step in
carcinogenesis. Compared to female breast cancer, little is known on the genetic makeup of …

Male breast cancer (MBC) is an uncommon and poorly understood disease. Recent
molecular studies have shown important differences from female breast cancer which are …

Background Male breast cancer (MBC) is a rare disease accounting for approximately 1% of
all breast carcinomas. Presently treatment recommendations are derived from the standards …

Purpose Because of its rarity, male breast cancer is often compared with female breast
cancer. Patients and Methods To compare and contrast male and female breast cancers, we …

Significant advances have been made in the diagnosis and treatment of female breast
cancer, resulting in a decline in incidence and a global improvement in clinical outcome …

Although rare, male breast cancer (MBC) remains a substantial cause for morbidity and
mortality in men. Based on age frequency distribution, age-specific incidence rate pattern …

It has become customary to extrapolate from the results of treatment trials for female
breastcancer and apply them to males with the disease. In the absence of results from …